This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter revenue fell 29.8%; profit after tax rose 12.9% to Rs 242 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 0.6 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the standalone quarter ended 30 Sep 2026: revenue fell 29.8% to Rs 11,761.19 lakh from Rs 16,764.30 lakh, while profit after tax rose 12.9% to Rs 242.01 lakh from Rs 214.42 lakh. Earnings before interest, tax, depreciation and other income improved from 0.55% to 3.26% of revenue. Standalone half-year loss after tax was Rs 83.17 lakh, with operating cash flow negative Rs 2,379.44 lakh. The limited review found no material misstatement.
Falling sales and cash burn are concerns, but quarterly profit and improved operating earnings margin may support sentiment despite half-year losses.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹117.6 Cr | ₹167.6 Cr | −29.8% |
| Operating profit | −₹2.16 Cr | −₹4.97 Cr | loss narrowed |
| Profit after tax | ₹2.42 Cr | ₹2.14 Cr | +12.9% |
| EBITDA margin | 3.3% | 0.6% | +2.7 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.